Table A1.
The Included Parameters in the Data Sets with Their Descriptions, Additional Information, and Variable Type.
Parameter | Description | Comment | Variable Type |
---|---|---|---|
Sex (female) | Percentage of female patients | N/A | Categorical |
BMI | Body Mass Index | N/A | Numerical |
Age (Q1, Q3) | Median age with 25th and 75th percentiles | N/A | Numerical |
SOFA | Total SOFA score | Ignores missing components | Numerical |
APACHE | Total APACHE II score | Ignores missing components | Numerical |
GCS score | Total Glasgow Coma Scale-score | N/A | Numerical |
ABP mean (mm Hg) | Arterial blood pressure (mean) | N/A | Numerical |
Heart rate (/min) | Heart rate | Either ECG, unspecified, or monitor | Numerical |
Hemoglobin (mmol/l) | Hemoglobin | Either arterial, blood, mixed venous, unspecified, venous, or bloodgas | Numerical |
AKI | The creatinine component of the AKI (Acute Kidney Injury) score | N/A | Numerical |
Urea/creatinine ratio | Urea over creatinine | N/A | Numerical |
PO2 arterial (mm Hg) | Partial pressure O2 (arterial) | N/A | Numerical |
Mean airway pressure (cmH2O) | Mean airway pressure | N/A | Numerical |
Peak pressure (cmH2O) | Peak pressure | N/A | Numerical |
PaO2/FiO2 | PaO2/FiO2 ratio | N/A | Numerical |
Tidal volume (ml/kg) | Tidal volume per ideal body weight | N/A | Numerical |
PCO2 arterial (mm Hg) | Partial pressure CO2 (arterial) | N/A | Numerical |
End tidal CO2 (mm Hg) | End-tidal CO2 | N/A | Numerical |
pH arterial | pH arterial | N/A | Numerical |
Respiratory system compliance (ml/cmH2O) | Respiratory system compliance | Either dynamic or unspecified | Numerical |
Driving pressure (cmH2O) | Driving pressure | N/A | Numerical |
Respiratory rate (/min) | Respiratory rate | Measured by ventilator | Numerical |
Ventilatory ratio | Ventilatory ratio | Calculated as: (minute ventilation (ml/min) · PaCO2 (mm Hg))/(predicted body weight · 100 · 37.5) | Numerical |
Mechanical power (joules/minute/kg PBW) | Mechanical power per predicted body weight | N/A | Numerical |
CRP (mg/l) | C-reactive protein | Either blood or unspecified | Numerical |
Temperature (°C) | Temperature in degrees Celsius | Either unspecified, rectal, esophageal, nasopharyngeal, groin, bladder, core, blood, axillary, or ear | Numerical |
Lymphocytes (%) | Lymphocytes percentage | N/A | Numerical |
APTT | Activated partial thromboplastin time | Either blood or unspecified | Numerical |
Prothrombin time (sec) | Prothrombin time | N/A | Numerical |
Anticoagulants | Percentage of patients with anticoagulants intake | Includes medications: heparin, dalteparin, enoxaparin, nadroparin, danaparoid, tinzaparin, clopidogrel, dipyridamole, carbasalate, epoprostenol, ticagrelor | Categorical |
Fluids | Percentage of patients with fluids intake | Includes medications: erythrocytes, thrombocytes, blood, solutions, carbohydrates, electrolytes | Categorical |
Vasopressors | Percentage of patients with vasopressors intake | Includes medications: isoprenaline, norepinephrine, dopamine, phenylephrine, dobutamine, epinephrine, ephedrine, milrinone, enoximone, vasopressin, desmopressin | Categorical |
Diuretics | Percentage of patients with diuretics intake | Includes medications: furosemide, bumetanide | Categorical |
Corticosteroids | Percentage of patients with corticosteroids intake | Includes medications: corticosteroids hydrocortisone, prednisolone, betamethasone, dexamethasone, betamethasone, dexamethasone, methylprednisolone, prednisolone, prednisone, hydrocortisone, cortisone, methylprednisolone | Categorical |
Other immunosuppressives | Percentage of patients with other immunosuppressives intake | Includes medications: anakinra, tocilizumab | Categorical |
Antibiotics | Percentage of patients with antibiotics intake | Includes medications: flucloxacillin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, meropenem, gentamicin, ciprofloxacin, vancomycin, metronidazole | Categorical |
Antimycotics | Percentage of patients with antimycotics intake | Includes medications: amphotericin, miconazole, ketoconazole, fluconazole, voriconazole, anidulafungin | Categorical |
Antivirals | Percentage of patients with antivirals intake | Includes medicationcyclovirvir, ganciclovir, valaciclovir, valganciclovir, ritonavir, oseltamivir, lopinavir, remdesivir | Categorical |
Musclerelaxants | Percentage of patients with musclerelexants intake | Includes medications: suxamethonium, rocuronium | Categorical |
Opioids | Percentage of patients with opioids intake | Includes medications: fentanyl, alfentanil, sufentanil, remifentanil, morphine, fentanyl, piritramide | Categorical |
Sedatives | Percentage of patients with sedatives intake | Includes medications: ketamine, etomidate, propofol, esketamine, diazepam, lorazepam, midazolam, dexmedetomidine | Categorical |